Low-Grade Adenosquamous Carcinoma of the Breast: Imaging and Histopathologic Characteristics of This Rare Disease  by Scali, Elena P. et al.
Canadian Association of Radiologists Journal 64 (2013) 339e344
www.carjonline.orgThoracic and Cardiac Imaging / Imagerie cardiaque et imagerie thoracique
Low-Grade Adenosquamous Carcinoma of the Breast: Imaging
and Histopathologic Characteristics of This Rare Disease
Elena P. Scali, MDa,*, Rola H. Ali, MDb, Malcolm Hayes, MDc, Scott Tyldesley, MDd,
Patricia Hassell, MDe
aDepartment of Radiology, University of British Columbia, Vancouver, British Columbia, Canada
bDepartment of Pathology, University of British Columbia, Vancouver, British Columbia, Canada
cDepartment of Pathology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
dDepartment of Radiology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
eDepartment of Radiation Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, CanadaAbstract
Low-grade adenosquamous carcinoma is a rare histologic subtype of breast carcinoma that has a variable mammographic and sonographic
appearance, which overlaps with both benign and malignant neoplasms. Because of its lack of unique imaging features, a diagnosis of low-
grade adenosquamous carcinoma is based on histopathology. The recognition of this entity is an important consideration in the differential
diagnosis of breast masses and carries implications for prognosis, which is more favorable than other types of breast carcinoma.Resume
Le carcinome adenosquameux d’evolution lente est une forme histologique rare du carcinome mammaire dont l’aspect mammographique
et echographique varie et qui recoupe les tumeurs benignes et malignes. Le diagnostic de carcinome adenosquameux d’evolution lente est
fonde sur l’histopathologie en raison de l’absence de caracteristiques d’imagerie propres a ce type de carcinome. En plus d’e^tre un element
important a prendre en compte dans le diagnostic differentiel des tumeurs mammaires, la reconnaissance de cette entite a des repercussions
sur le pronostic, qui est plus favorable que pour d’autres types de carcinome mammaire.
 2013 Canadian Association of Radiologists. All rights reserved.
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grade adenosquamous carcinoma of the breast (LGAS) is
a type of invasive mammary carcinoma. It is a histopatho-
logic subtype of metaplastic carcinoma of the breast (MCB),
a rare and heterogeneous group of neoplasms that constitute
<5% of all breast carcinomas [2,3]. The clinical presentation
of LGAS is most commonly a painless, palpable mass, with an
age distribution similar to other breast carcinomas [1,4e8]. Its
mammographic and sonographic appearance is nonspecific
and shares features of both benign and malignant neoplasms,
including fibroadenoma and invasive ductal and invasive
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managed similar to invasive carcinoma.Imaging Features of LGAS
The radiology literature mainly focuses on the general
class of metaplastic breast carcinoma; imaging descriptions
of LGAS are rare and limited to case reports and small series
[4,5,7]. Available descriptions of LGAS suggest nonspecific
imaging findings with no pathognomonic features.
Mammographic features include solid masses with a nodular
or stellate appearance [4,5]. Margins may be spiculated or
poorly defined [4,5]. Microcalcifications have been reported
but are uncommon [1,4,5,8]. Sonographic features may
include a solid, irregular hypoechoic mass with ill-defined
borders [4,7].ll rights reserved.
Figure 1. (A) Mammograms, showing ill-defined asymmetry (arrow) of the
retroareolar region of the left breast, without the presence of a definite mass.
(B) The normal-appearing right breast is shown for comparison.
Figure 3. Radiograph of biopsy specimen from the left breast, showing
a round mass (short arrows) with well-defined margins and benign calcifi-
cations (long arrow) detected on screening mammography.
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On histologic examination, LGAS exhibits both glandular
and squamous differentiation, and exhibits immunoex-
pression of myoepithelial markers [1,7,9]. It features a stel-
late or infiltrating configuration with poorly defined margins
compared with the firm, nodular, and well-circumscribedFigure 2. Mammograms, showing malignant-type calcifications (arrow) in
the left breast on medial lateral oblique view.appearance generally found in high-grade MCBs. By defi-
nition, LGAS is classified as a low- or intermediate-grade
tumour when using the Nottingham grading system.
LGAS may be difficult to diagnose on histologic exami-
nation, because its appearance mimics benign or other low-Figure 4. Mammogram of the right breast, showing a mass with spiculated
borders (arrow) on medial lateral oblique view.
Figure 5. Mammogram of the right breast, showing a well-defined oval mass
laterally with spiculated appearance medially (arrow).
341Low-grade adenosquamous carcinoma of the breast / Canadian Association of Radiologists Journal 64 (2013) 339e344grade lesions [1,4]. It features an infiltrative pattern, with
small round-to-irregular tubular glands embedded in dense
collagenized stroma. In addition, it exhibits low-grade
cytologic atypia, few mitoses, and a lack of necrosis [1,4].Figure 6. (A) Mammogram, showing a spiculated mass (arrow) in the retroareolar
image of the right breast, showing an irregular hypoechoic mass with spiculatedLGAS may be difficult to recognize on fine needle aspiration
cytology, core needle biopsy, and intraoperative frozen
sections. Often, an excision biopsy is required to establish
a definitive diagnosis.
Clinical Features of LGAS
The clinical course and prognosis of LGAS differs from
the broader category of MCB. Clinically, most MCB are
characterized by aggressive behavior, with a high rate of
metastases at diagnosis, chemoresistance, and poorer clinical
outcome than other breast malignancies [10e13]. By
contrast, LGAS has a more favorable prognosis and tends
towards an indolent clinical course. Although risk for local
recurrence has led to aggressive local treatment (eg, wide
local excision or mastectomy) to achieve clear margins, there
is a very low incidence of axillary lymph node involvement
and metastatic disease [7,9,14]. Overall, LGAS are consid-
ered to be low-grade tumours with an excellent prognosis.
Study Design
A retrospective review was conducted of patients referred
to the British Columbia Cancer Agency who were diagnosed
with LGAS between 1989 and 2010. Twenty-two cases were
found, 10 of which had the imaging available, which made
these patients eligible for inclusion in our study. Mammo-
graphic (n ¼ 8) and sonographic (n ¼ 7) findings were
analysed together with pathologic findings, with follow-up
over 2-11.5 years.region of the right breast on the medial lateral oblique view. (B) Ultrasound
superior border and dense, posterior acoustic shadowing (arrow).
Figure 7. Sagittal ultrasound, showing an oval-shaped, multilobulated,
hypoechoic lesion, with sharply defined borders.
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The patient age range was 30-81 years, with a mean age of
64.8 years. The presenting symptom was a palpable abnor-
mality in 5 patients, nonpalpable mass identified by
screening mammography in 1 patient, and suspiciousFigure 8. Ultrasound of the right breast in transverse view, showing a round,
hypoechoic, homogeneous mass with indistinct margins (arrow).calcifications identified by screening mammography in 2
patients. Nipple changes, including nipple retraction in 1
patient and nipple hardening in 1 patient, were also pre-
senting symptoms. The size of lesions on screening
mammography ranged from 0.7-3.0 cm, with an average size
of 1.8 cm. Calcifications were detected in 2 patients.Figure 9. (A) Right breast transverse ultrasound, showing a round mass with
circumscribed, lobular margins, and internal cystic areas (arrow). (B) Needle
core biopsy using hematoxylin and eosin stain, showing scattered benign-
looking glands (arrows), which may be misinterpreted as normal
mammary glands. (C) High-power view of low-grade adenosquamous
carcinoma, showing the glandular component (black arrow) and squamous
component (blue arrow). Magnification: (B) 4; (C) 40. This figure is
available in colour online at http://carjonline.org/.
Table 1
Mammographic and sonographic features of low-grade adenosquamous carcinoma
Patient
no. Age, y
Mammographic features Sonographic features
Presentation Size, cm Shape Margin Size, cm Shape Margin Echogenicity
1 30 2.8 Oval Multilobulated, W-D Hypoechoic
2 71 SM: Caþþ 0.7 Pleomorphic N/A
3 81 PM 1.5 Oval I-D 1.5 Irregular I-D, angular Hypoechoic, posterior
shadowing
4 63 1.1 Round I-D Hypoechoic
5 72 PM 1.5 Round W-D 1.2 Oval W-D Hypoechoic, cystic areas
6 81 Nipple retraction 1.9 Round W-D 1.5 Round W-D Hypoechoic
7 75 Nipple hardness 2.0 Asymmetrical
density
W-D
8 50 SM: Caþþ 3.0 Round W-D
9 76 PM 1.6 Irregular W-D 1.8 Irregular,
taller > wide
I-D, spiculated Hypoechoic, complex
cystic area
10 49 PM 2.0 Spiculated mass I-D 2.5 Irregular Spiculated Hypoechoic, dense after
shadowing
Caþþ ¼ calcifications; I-D ¼ ill defined; N/A ¼ not applicable; PM ¼ palpable mass; SM ¼ screening mammography; W-D ¼ well defined.
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metry (Figure 1A, B), malignant-type calcifications
(Figure 2), a well-defined mass with calcifications (Figure 3),
and a spiculated mass (Figures 4 to 6A) were observed.
Sonographic findings included acoustic shadowing
(Figure 6B) and hypoechoic lesions with sharply-defined
(Figure 7) and poorly defined borders (Figure 8) as well as
internal cystic areas (Figure 9A). The mammographic and
sonographic features of the patients included in the study are
summarized in Table 1.
Onpathologic examination, LGAS specimens demonstrated
scattered benign-looking glandular and squamous components,
which were often challenging to recognize due to their similar
appearance to normal mammary glands (Figure 9B, C).
Microscopic calcifications were largely absent, seen only in
a minority of cases. There were no in situ components. There
were no metastasis to axillary lymph nodes or systemic
metastases. In all cases, tumour makers were triple negative for
the estrogen receptor (ER), progesterone receptor (PR) and
human epidermal growth factor receptor 2 (HER2/neu).
Treatment and Follow-up
The management of low-grade adenosquamous carcinoma
varied among patients. In terms of surgical management, 3
patients underwent mastectomies and 7 patients underwent
breast-conserving surgery. Seven of the patients had axillary
node dissection performed, none of which showed positive
nodes. Seven of the patients had radiation therapy. One patient
had chemotherapy. The follow-up of the patients in this study
ranged from 2-11.5 years, with an average of 6.5 years.
Consistent with the majority of cases in the published litera-
ture, there were no cases of distant metastases after definitive
therapy. Retrospectively, however, 1 patient was diagnosed
with local recurrence. Six years before her diagnosis of
LGAS, she detected a mass that was surgically removed and
originally called benign. She presented again with a mass in
the same area, and the pathology from her previous mass was
reviewed and the diagnosis of LGAS was made.Conclusion
In this study, LGAS was found to present as a solid mass
with a variety of mammographic and sonographic findings,
and no unique imaging features. Lesions were most
commonly periareolar in location and with few associated
calcifications. None of the patients had a positive axillary
dissection, and all of the tumours were hormone receptor
negative. Only one of the tumours in our study recurred, and
none metastasized. These findings are consistent with the
published literature.
The imaging appearance of LGAS in this study overlaps
with other benign and malignant neoplasms, including
fibroadenoma and invasive ductal and invasive lobular
carcinomas. As a result, LGAS cannot be diagnosed with
confidence based on imaging alone; biopsy with pathologic
diagnosis is essential to definitive establish the tumour type.
The findings in this group of patients with pathology-
proven LGAS underscore the indolent clinical course
observed in the published literature. In light of the absence of
lymph-node involvement and systemic metastasis, this begs
the question as to whether patients have been overtreated in
the past. Although the role of wide local excision is well
established, the use of adjuvant treatment such as chemo-
therapy and radiation are of questionable benefit.References
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